Total Mesorectal Excision with or without Lateral Pelvic Lymph Node Dissection in Rectal Cancer

Table 2

Comorbidity and ASA distribution.

		Group A		Group B		value
		Count	%	Count	%
DM	Yes	10	21.7	10	21.7	1
	No	36	78.3	36	78.3
HTN	Yes	8	14.4	6	13.0	1
	No	38	82.6	40	87.0
ASA	Group A	ASA 1…28 patients, ASA 2…10, ASA 3…8				1
	Group B	ASA 1…26 patients, ASA 2…8, ASA 3…12